RET and multiple endocrine neoplasia type 2A: In MEN 2A the RET mutation occur in the extracellular domain of the RET and causes ligand-independent activation of PI3K–AKT, RAS, p38 MAPK and JUN N-terminal kinase pathways, resulting in the stimulation of cell growth, differentiation and survival.